A cell-surface β-hydroxylase is a biomarker and therapeutic target for hepatocellular carcinoma
about
The Eighth Central European Conference "Chemistry towards Biology": SnapshotProteomic profile and in silico analysis in metastatic melanoma with and without BRAF mutationAspartate-β-hydroxylase induces epitope-specific T cell responses in hepatocellular carcinomaHigh level of intercellular adhesion molecule-1 affects prognosis of patients with hepatocellular carcinoma.Anti-Tumor Effects of Second Generation β-Hydroxylase Inhibitors on Cholangiocarcinoma Development and Progression.Activation of signal transduction pathways during hepatic oncogenesisOptimized Expression and Purification of Humbug in Pichia pastoris and Its Monoclonal Antibody Preparation.Aspartate β-hydroxylase modulates cellular senescence through glycogen synthase kinase 3β in hepatocellular carcinoma.Upregulation of colonic and hepatic tumor overexpressed gene is significantly associated with the unfavorable prognosis marker of human hepatocellular carcinoma.Aspartate-β-hydroxylase (ASPH): A potential therapeutic target in human malignant gliomas.Role of Notch signaling pathway in pancreatic cancer.Role of the Notch signaling in cholangiocarcinoma.Lambda phage-based vaccine induces antitumor immunity in hepatocellular carcinoma.The Forty-Sixth Euro Congress on Drug Synthesis and Analysis: Snapshot †.Ethanol-Induced White Matter Atrophy Is Associated with Impaired Expression of Aspartyl-Asparaginyl-β-Hydroxylase (ASPH) and Notch Signaling in an Experimental Rat Model.MiR-200a inhibits cell proliferation and EMT by down-regulating the ASPH expression levels and affecting ERK and PI3K/Akt pathways in human hepatoma cells.Hydroxylase Activity of ASPH Promotes Hepatocellular Carcinoma Metastasis Through Epithelial-to-Mesenchymal Transition Pathway.
P2860
Q28817788-FE0401DA-2051-4408-BF0D-96BE61724682Q34599527-DB1D1045-4457-4E0D-85F8-CB5991931595Q35091441-5EE0FB05-DC3B-4B3E-814F-6E7EFE9E249FQ35767923-B7E9B3E2-D597-406D-A3A5-9F8A3AC6E0A6Q35949450-EFF27B99-6EC7-4D6D-BE83-DE0BDD436BA5Q36386273-DF2BF30F-B242-480A-897F-A650931EB959Q36495723-692D613A-E049-48A2-A6E0-20582132C193Q36723189-0AF288D1-9520-4B6C-9A5D-AF35A341A009Q36853891-4A0B1961-6F62-467C-BE52-967C60C63CDAQ37485171-F784D8EA-EF25-4283-BFC3-5FBD3815D963Q37679979-03CC9DA4-2FB6-4AF2-8A48-2ACDB1A9C6E6Q39192384-BDD2F6C0-D259-400F-BACD-78BA624DFB0FQ42366399-87B51D9D-5E82-4C31-8C20-0B51D49AD6D7Q47215879-3E9D5343-4589-45B9-B42E-65556FB63E87Q47331366-B9EA0F59-5BC3-47D8-BB8C-015F7E9623EFQ54111731-F28E554E-C079-4D4D-BF27-AF43607D916BQ55378664-C7C7A5D2-8F4F-4327-A771-7385C69A5A70
P2860
A cell-surface β-hydroxylase is a biomarker and therapeutic target for hepatocellular carcinoma
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A cell-surface β-hydroxylase i ...... t for hepatocellular carcinoma
@ast
A cell-surface β-hydroxylase i ...... t for hepatocellular carcinoma
@en
A cell-surface β-hydroxylase i ...... t for hepatocellular carcinoma
@nl
type
label
A cell-surface β-hydroxylase i ...... t for hepatocellular carcinoma
@ast
A cell-surface β-hydroxylase i ...... t for hepatocellular carcinoma
@en
A cell-surface β-hydroxylase i ...... t for hepatocellular carcinoma
@nl
prefLabel
A cell-surface β-hydroxylase i ...... t for hepatocellular carcinoma
@ast
A cell-surface β-hydroxylase i ...... t for hepatocellular carcinoma
@en
A cell-surface β-hydroxylase i ...... t for hepatocellular carcinoma
@nl
P2093
P2860
P356
P1433
P1476
A cell-surface β-hydroxylase i ...... t for hepatocellular carcinoma
@en
P2093
Arihiro Aihara
Chiung-Kuei Huang
Jack R Wands
Qiushi Lin
Waihong Chung
Xiaoqun Dong
P2860
P304
P356
10.1002/HEP.27275
P407
P577
2014-08-25T00:00:00Z